About Us
Our Labs
Resident Innovators
Ignite
News & Events
Careers
Contact
Apply For Residency
Login
Careers
Contact
Apply For Residency
Login
About Us
Our Labs
Resident Innovators
Ignite
News & Events
Open main menu
Press Releases
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Patients with Relapsed/Refractory B-cell Lymphoma
June 20, 2016
Share :
Previous Page
Next Page